TheraRadar
← Back
Data updated: Mar 29, 2026

ANACOR PHARMS INC

OncologyDermatologyInfectious Disease
Pharma

ANACOR PHARMS INC is a pharmaceutical company focused on Oncology, Dermatology, Infectious Disease. Key products include EUCRISA.

2014
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

EUCRISA
crisaborole
Immunology
PDE-4 1 indications · 2016

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 42%
0 drugs Phase 3: 3 Phase 1: 2
Dermatology 33%
1 drugs Phase 3: 1 Phase 1: 1
Infectious Disease 24%
0 drugs Phase 3: 1 Phase 2: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology